| 0 |
INCREASED DOSE ADMINISTERED |
1 |
0.0032 |
| 1 |
DIALYSIS RELATED COMPLICATION |
1 |
0.0028 |
| 2 |
PERICARDITIS CONSTRICTIVE |
1 |
0.0024 |
| 3 |
EMBOLIC CEREBRAL INFARCTION |
1 |
0.0015 |
| 4 |
URETEROLITHIASIS |
1 |
0.0010 |
| 5 |
IMMEDIATE POST-INJECTION REACTION |
1 |
0.0009 |
| 6 |
CHEMICAL BURN |
1 |
0.0009 |
| 7 |
RECTAL ULCER |
1 |
0.0009 |
| 8 |
BLOOD ELECTROLYTES ABNORMAL |
1 |
0.0008 |
| 9 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
1 |
0.0007 |
| 10 |
SHOULDER FRACTURE |
1 |
0.0006 |
| 11 |
ABDOMINAL WALL HAEMATOMA |
1 |
0.0005 |
| 12 |
SUDDEN HEARING LOSS |
1 |
0.0005 |
| 13 |
DIVERTICULAR PERFORATION |
1 |
0.0005 |
| 14 |
BLOOD PHOSPHORUS INCREASED |
1 |
0.0004 |
| 15 |
PRE-EXISTING CONDITION IMPROVED |
2 |
0.0003 |
| 16 |
RENAL TRANSPLANT |
1 |
0.0003 |
| 17 |
LIVER TRANSPLANT |
1 |
0.0003 |
| 18 |
ENTEROCOCCAL INFECTION |
1 |
0.0002 |
| 19 |
HYPERVOLAEMIA |
1 |
0.0002 |
| 20 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
1 |
0.0002 |
| 21 |
GASTRIC ULCER HAEMORRHAGE |
1 |
0.0002 |
| 22 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
1 |
0.0001 |
| 23 |
BLOOD IRON DECREASED |
1 |
0.0001 |
| 24 |
PRODUCT TASTE ABNORMAL |
1 |
0.0001 |
| 25 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 26 |
INSURANCE ISSUE |
1 |
0.0001 |
| 27 |
OSTEOMYELITIS |
1 |
0.0001 |
| 28 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 29 |
CHOKING |
1 |
0.0001 |
| 30 |
PRESCRIBED UNDERDOSE |
1 |
0.0001 |
| 31 |
FEEDING DISORDER |
1 |
0.0000 |
| 32 |
RETCHING |
1 |
0.0000 |
| 33 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 34 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 35 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
0.0000 |
| 36 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 37 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 38 |
SKIN ULCER |
1 |
0.0000 |
| 39 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 40 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0000 |
| 41 |
HYPERSOMNIA |
1 |
0.0000 |
| 42 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 43 |
SEPTIC SHOCK |
1 |
0.0000 |
| 44 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 45 |
THROAT IRRITATION |
1 |
0.0000 |
| 46 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 47 |
CELLULITIS |
1 |
0.0000 |
| 48 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 49 |
BLISTER |
1 |
0.0000 |
| 50 |
NASAL CONGESTION |
1 |
0.0000 |
| 51 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 52 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 53 |
MOBILITY DECREASED |
1 |
0.0000 |
| 54 |
DYSGEUSIA |
1 |
0.0000 |
| 55 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 56 |
COVID-19 |
2 |
0.0000 |
| 57 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 58 |
SWELLING |
1 |
0.0000 |
| 59 |
ANAEMIA |
2 |
0.0000 |
| 60 |
CONTUSION |
1 |
0.0000 |
| 61 |
HEART RATE INCREASED |
1 |
0.0000 |
| 62 |
SYNCOPE |
1 |
0.0000 |
| 63 |
ILLNESS |
1 |
0.0000 |
| 64 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 65 |
DECREASED APPETITE |
2 |
0.0000 |
| 66 |
DEHYDRATION |
1 |
0.0000 |
| 67 |
COUGH |
2 |
0.0000 |
| 68 |
HOSPITALISATION |
1 |
0.0000 |
| 69 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 70 |
ASTHENIA |
2 |
0.0000 |
| 71 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 72 |
HYPERTENSION |
1 |
0.0000 |
| 73 |
CONSTIPATION |
1 |
0.0000 |
| 74 |
WEIGHT INCREASED |
1 |
0.0000 |
| 75 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 76 |
NAUSEA |
3 |
0.0000 |
| 77 |
WEIGHT DECREASED |
1 |
0.0000 |
| 78 |
DIARRHOEA |
2 |
0.0000 |
| 79 |
FALL |
1 |
0.0000 |
| 80 |
FATIGUE |
2 |
0.0000 |
| 81 |
ARTHRALGIA |
1 |
0.0000 |
| 82 |
RASH |
1 |
0.0000 |
| 83 |
MALAISE |
1 |
0.0000 |
| 84 |
VOMITING |
1 |
0.0000 |
| 85 |
DIZZINESS |
1 |
0.0000 |
| 86 |
DYSPNOEA |
1 |
0.0000 |
| 87 |
PAIN |
1 |
0.0000 |
| 88 |
HEADACHE |
1 |
0.0000 |
| 89 |
DRUG INEFFECTIVE |
2 |
0.0000 |